在HSCT患者中的伊萨夫康纳-塔克罗利斯药物相互作用
L Fructuoso-González1, M D Najera-Perez1, N Manresa-Ramón1
1Hospital Pharmacy Service, Hospital Morales Meseguer, Murcia, Spain.
The Journal of antimicrobial chemotherapy
|September 5, 2023
概括
将 isavuconazole (ISA) 添加到免疫抑制剂 tacrolimus 中,将 tacrolimus 的水平提高了 44%. 这表明,可能需要减少18%的塔克罗利斯剂量,以防止干细胞移植患者的毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 免疫抑制是一种免疫抑制.
- 血液学 血液学 血液学
背景情况:
- 塔克罗利莫斯是一种氨酸抑制剂 (CNI),具有狭窄的治疗窗口和显著的可变性.
- 管理免疫抑制对于预防移植拒绝和确保在血造干细胞移植 (HSCT) 接受者的移植至关重要.
- 伊萨夫可纳 (ISA) 是一种较新的三醇抗真菌药,用于侵入性真菌感染的预防.
研究的目的:
- 为了确定伊萨武科纳 (ISA) 对塔克罗利斯药理动学的影响.
- 为了确定与ISA同时服用塔克罗利斯的推剂量减少.
- 为了防止塔克罗利斯的毒性,并确保在HSCT接受者身上进行移植.
主要方法:
- 在11名HSCT接受者中评估ISA和塔克罗利斯之间的相互作用.
- 在ISA给药前后计算塔克罗利斯度/剂量 (C/D) 比率.
- 对C/D比率变化的统计分析.
主要成果:
- 塔克罗利莫斯C/D比率的平均值比基线增加了1.44倍,比ISA后48小时增加了1.44倍.
- 这种增加在统计学上是显著的 (P = 0.001).
结论:
- 伊萨夫可纳可显著增加塔克罗利斯水平.
- 当与ISA一起使用时,可能需要减少18%的塔克罗利斯剂量.
- 需要进一步的研究来证实这些发现,并优化剂量策略.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
551
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
551
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Pulmonary Tuberculosis I
265
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
265
Drug Dosage Regimen: Overview
3.6K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.6K
Factors Affecting Protein-Drug Binding: Drug Interactions
195
Drug interactions are a critical aspect of pharmacology and can occur when two or more drugs compete for the same binding site. This competition can result in one drug displacing another, altering the effect of the displaced drug. Drug interactions are complex processes that rely heavily on how much of the displacer drug is present and how strongly it can bind to the same sites as the displaced drug.
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
195
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
149
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
149


